A detailed history of Pictet Asset Management Holding Sa transactions in Exact Sciences Corp stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 68,802 shares of EXAS stock, worth $3.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,802
Previous 66,927 2.8%
Holding current value
$3.76 Million
Previous $4.62 Million 37.11%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $77,493 - $139,237
1,875 Added 2.8%
68,802 $2.91 Million
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $56,945 - $74,655
1,012 Added 1.54%
66,927 $4.62 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $605,424 - $776,205
-10,251 Reduced 13.46%
65,915 $4.88 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $5.02 Million - $7.54 Million
76,166 New
76,166 $5.2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.68B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.